Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of HL-1186 in Diabetic Peripheral Neuropathic Pain
ChiCTR2500107621Phase 2Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HL-1186 in diabetic polyneuropathy (DPN) (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Numeric pain rating scale (ADPS). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
HL-1186
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR2500107621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107621.